Sunshine Biopharma Inc (SBFM)

[TenKay]

The issue isn’t so much when the study was but that they never were able to get to Phase 1 clinical trials....and it’s not like they just decided now to go that route...they started out of the gate when that study was published in 2012. But it didn’t happen. There is a reason for that.

If that drug had any real potential it would not have been sitting in the shelf for the last 9 years.

And this is a well worn narrative in the OTC. A drug that attracted some funding for lab tests years ago but could never go beyond that...many years later becoming the central “story” for the OTC stock.